• Study on the Effect of Adding Thoracic Radiotherapy to Durvalumab and Chemotherapy for Patients with Extensive Stage Small-Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Estonia Iceland The Netherlands Norway Sweden

  • Study of Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone for Patients with Newly Diagnosed AL Amyloidosis with Heart Involvement

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Greece Italy The Netherlands Spain

  • Study on [68Ga]Ga-PentixaFor and [18F]FDG PET/CT Imaging for Staging Marginal Zone Lymphoma in Patients with Confirmed Diagnosis

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria France Germany Italy Spain

  • Study on Long-Term Effects of Mirikizumab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia Denmark France Hungary +8

  • Study on Larotrectinib for Treating Children with Advanced Solid Tumors with NTRK Fusion

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark France Germany Ireland Italy +3

  • Study on the Long-term Safety and Effects of AL002 and Florquinitau F18 in Patients with Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Poland Spain

  • Study Comparing Obinutuzumab and Venetoclax with Obinutuzumab and Chlorambucil for Untreated Chronic Lymphocytic Leukemia Patients with Other Health Conditions

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Bulgaria Croatia Denmark Estonia France +5

  • Study on the Safety and Effectiveness of Telisotuzumab Vedotin for Patients with Previously Treated c-Met Positive Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Greece Ireland Italy +2

  • Study on the Safety and Effectiveness of Pembrolizumab, Vibostolimab, and Lenvatinib for Patients with PD-1 Refractory Melanoma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy

  • Study on Dulaglutide for Preventing Diabetes in New Kidney Transplant Patients

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

powered by